Signal active
Organization
Contact Information
Overview
Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.
The company delivers digitally and genomically-driven medical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.
About
Health Care, Medical, Neuroscience
2019
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Mable (Neurolytic Healthcare) headquartered in Europe, operates in the Health Care, Medical, Neuroscience sector. The company focuses on Health Care and has secured $156.0M in funding across 48 round(s). With a team of 11-50 employees, Mable (Neurolytic Healthcare) is actively contributing to advancements in Health Care. Their latest funding round, Pre Seed Round - Mable (Neurolytic Healthcare), raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
4
2
0
$3.3M
Details
3
Mable (Neurolytic Healthcare) has raised a total of $3.3M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2021 | Seed | 50.0K | ||
2022 | Seed | 3.2M | ||
2022 | Seed |
Investors
Mable (Neurolytic Healthcare) is funded by 12 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Inaki Berenguer | - | FUNDING ROUND - Inaki Berenguer | 3.2M |
Y Combinator | - | FUNDING ROUND - Y Combinator | undefined |
Mable (Neurolytic Healthcare) | - | FUNDING ROUND - Mable (Neurolytic Healthcare) | undefined |
Illumina | - | FUNDING ROUND - Illumina | undefined |
Recent Activity
There is no recent news or activity for this profile.